Clarity Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-39
Closed -$4.65K 197
2026
Q1
$4.65K Buy
39
+1
+3% +$115 ﹤0.01% 249
2025
Q4
$4.04K Hold
38
﹤0.01% 214
2025
Q3
$3.19K Hold
38
﹤0.01% 218
2025
Q2
$3.01K Hold
38
﹤0.01% 221
2025
Q1
$3.41K Hold
38
﹤0.01% 190
2024
Q4
$3.78K Hold
38
﹤0.01% 185
2024
Q3
$4.32K Hold
38
﹤0.01% 167
2024
Q2
$4.7K Hold
38
﹤0.01% 156
2024
Q1
$5.01K Hold
38
﹤0.01% 161
2023
Q4
$4.14K Buy
+38
New +$3.94K ﹤0.01% 167

Other funds holding MRK

Clarity Asset Management's MRK Position: Q2 2026 in Review

Clarity Asset Management sold out of Merck (MRK) in Q2 2026, closing a stake of 39 shares — an estimated $4.65K sold.

Clarity Asset Management first reported a position in MRK in Q4 2023 and held it in 10 quarters. The position peaked at $5.01K in Q1 2024. 1,303 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Clarity Asset Management reported no remaining Merck position as of Q2 2026 after selling out during the quarter.
  • Clarity Asset Management sold 39 Merck shares in Q2 2026, an estimated $4.65K.
  • Clarity Asset Management first reported a position in Merck in Q4 2023 and held it in 10 quarters.
  • Clarity Asset Management's Merck position peaked at $5.01K in Q1 2024.
  • 1,303 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Clarity Asset Management's 13F filing for Q2 2026, filed 16 Jul 2026.